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Summary:
Psychosomatic disorders are extremely common in patients in non-psychiatric departments. It is widely known 
that in these cases comorbid psychiatric disorders are highly prevalent and that the importance of psychoso-
cial factors is relevant. However, it is still a challenge for both internal medicine and mental health profession-
als to diagnose and treat them effectively. The need of evidence-based treatment guidelines for clinicians is 
obvious. As far as it is concerned, DSM-5 has redefined the criteria of somatoform disorders, underlying the 
importance of incorrect thoughts about symptoms whether organic ethiology.
Methods/Design: The aim was to provide an insight into the barriers of diagnosing psychosomatic disorders 
in cardiology referring to possible psychiatric comorbidity. Over 150 actual abstracts and full text manuscripts 
were checked. The literature published in English and Polish, mostly in PubMED/MEDLINE, PsycINFO, EM-
BASE, Cochrane Database of Systematic Reviews of past 10 years was studied and compared to the liter-
ature of psychoanalytic theory. Disscussion: It is worth to remember, that for high proportion of patients with 
mental disorders somatic syndrome is the only symptom they report to physicians. Emotion regulation theo-
ry, alexithymia theory and desomatization and resomatization theory find it as the effect of unsolved problems 
with emotions. Moreover, functional neuroimaging studies seem to reveal coherent findings. Based on it, the 
neurophysilogical model of emotion regulation and the mechanism of cognitive-emotional executive control 
were described. Accordingly, literature shows that in heart disease patients the incorporation of psychological 
interventions in healing process significantly reduces mortality and relapse.
INTRODUCTION
In	medical	practice	we	often	meet	patients	
with somatic symptoms without organic cause. 
This	circumstance	makes	it	necessary	to	think	
holistically, adding new areas of activity to the 
diagnostic and therapeutic pathways of internal 
medicine.	In	many	cases	problems	reported	by	
patients are accompanied by undiagnosed men-
tal health problems, which are often an impor-
tant	risk	factor	for	serious	somatic	diseases.	This	
paper aims to draw attention to the symptoms of 
cardiovascular system dysfunctions which, em-
bedded in the context of psychopathology, will 
not only enable full diagnosis, but also an effec-
tive	treatment	[1].	It	presents	the	current	state	
of	knowledge	about	psychosomatic	symptoms.
Literature is full of vagueness and ambiguities 
of terms related to the definition of psychoso-
matic illnesses [2]. The very concept of somatiza-
tion,	according	to	Wilhelm	Steckel	a	psychoana-
lyst who introduced this term, means a tenden-
cy to being more aware of physical than men-
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tal aspects of emotional states and expressing 
emotional suffering by means of somatic symp-
toms	[3].	The	ICD-10	lacks	a	separate	diagnostic	
category related to psychosomatic illnesses. This 
term occurs primarily in relation to disorders in 
somatic	form	(ICD-10),	and	somatoform	disor-
ders	(DSM-IV).	Due	to	restrictive	criteria,	the	
categories	capture	only	severe	conditions.	Rask	
et al. demonstrated in their study possible clin-
ical benefits of the new category labelled ‚mul-
tiple symptoms’, which was addressing sub-
threshold categories of medically unexplained 
symptoms	(MUS)	classified	as	somatoform	dis-
order	[4].	 In	DSM-5	several	modifications	 in	
this	category	have	been	done.	In	addition	to	the	
changes in nomenclature, one of the most impor-
tant	changes	is	the	lack	of	need	to	exclude	organ-
ic cause to diagnose the somatoform disorder. 
More	important	is	that	somatic	symptoms	are	
accompanied by inadequate thoughts, feelings 
and behaviors related to symptoms [5].
Because of the inadequacy of the classic psy-
chiatric	nosography	for	the	concept	of	this	kind	
of diseases, in 1995 The Diagnostic Criteria for 
Psychosomatic	Research	(DCPR)	were	 intro-
duced.	This	12	„psychosomatic	syndromes”	pro-
vided operational tools for psychosocial varia-
bles and its’ prognostic and therapeutic implica-
tions in clinical settings. Eight syndromes con-
cern the main manifestations of abnormal illness 
behavior	(persistent	somatization,	functional	so-
matic symptoms secondary to a psychiatric dis-
order, conversion symptoms, anniversary reac-
tion, disease phobia, thanatophobia, health anxi-
ety, illness denial) and the other four syndromes 
refer to the domain of psychological factors af-
fecting	medical	conditions	(alexithymia,	type	
A	behavior,	demoralization,	irritable	mood).	Sir-
ri	and	Fava	made	the	comparison	of	the	DCPR,	
DSM-IV	and	DSM-5	proposal.	In	their	opinion	
the	12	DCPR	syndromes,	being	more	sensitive,	
may broaden the physician’s perspective on pa-
tients’ problems, capturing psychological vari-
ables which do not find room in the customary 
psychiatric classification [6].
It	is	worth	noting	that	besides	the	diagnoses	
of psychosomatic disorders, symptoms local-
ised in the body are characteristic for the diag-
nosis	of	many	other	mental	disorders.	In	masked	
depression, the main complaint may be a prob-
lem with circulatory system that disappear af-
ter treatment with antidepressants. Faster heart 
rate and breathing, tremors, palpitations, short-
ness	of	breath,	chest	discomfort,	dizziness,	fear	
of death, are some of the functional symptoms of 
autonomic arousal and manifest themselves sim-
ilarly to cardiovascular problems. They can oc-
cur in the course of social phobia, panic disorder, 
specific phobias, as a part of an acute stress re-
action, in patients addicted to psychoactive sub-
stances, in conversion disorder or in alexithym-
ic patients.
Psychosomatic syndromes in hospital emergency 
department, Primary Health Care and day hospital 
for neurotic disorders treatment
Patients reporting symptoms without organic 
cause of a disease are especially common in hos-
pital	emergency	departments	(HED)	and	prima-
ry	health	care	(PHC).	The	most	common	com-
plaint	is	pain	in	the	chest.	It	may	be	a	symptom	
of coronary artery disease or myocardial infarc-
tion, which is one of the most terrifying condi-
tions for patients [7-8]. According to numerous 
studies, in emergency departments the diagno-
sis of organic cause of the ailment is excluded in 
30%	to	77%	of	patients	[9-12].	A	comparable	pro-
portion of patients in primary health care, i.e. be-
tween	22%	and	58%,	report	somatic	complaints	
that	are	not	of	organic	nature	[13].	Sobański	et	
al.	revealed	that	also	75%	of	patients	admitted	
to the day hospital for neurotic disorders treat-
ment	submitted	“pseudocardiac	symptoms”	of	
tachycardia/palpitations	and	chest	pain	[14].	In	
non-psychiatric units the diagnosis of the symp-
toms commonly ends at this point. Despite the 
good prognosis, the presence of chest pain with 
no evidence of organic heart disease frequently 
causes withdrawal from social activities at a lev-
el comparable to patients suffering from coro-
nary	artery	disease	[15].	It	is	known	that	mental	
health problems themselves may trigger, main-
tain, or even worsen pain in the chest [16]. Ex-
clusion of organic cause of symptoms without 
explaining other possible causes, in many cas-
es is not enough to reassure patients who are 
concerned about their health [17]. Even perform-
ing diagnostic tests to rule out heart disease can 
strengthen the patient’s belief in struggling with 
a	serious	health	problem	[18].	In	addition,	anx-
68	 Anna	Ostachowska	et	al.
Archives of Psychiatry and Psychotherapy, 2015; 4: 66–76
iety may be accompanied by reduced level of 
quality	of	life	(QoL),	the	incidence	of	consecu-
tive episodes of chest pain, overuse of health 
care	[19]	and	withdrawal	from	social	roles.	It	has	
been observed that in primary care patients who 
reported more than five symptoms, increased 
impairment of social roles occurred more fre-
quently when these symptoms had no medical 
explanation than when they were results of or-
ganic dysfunctions [20].
What is more, the study on the costs of soma-
tization	in	English	population	shows	that	only	
mental health care service is the one that does 
not	show	significantly	increased	rates	of	utiliza-
tion	by	somatizing	patients	[21].	We	can	assume	
that	on	the	one	hand	this	kind	of	patients	tend	
to ignore their mental ailments and communi-
cate their emotional states by somatic symp-
toms, usually being misunderstood by physi-
cians.	On	the	other	hand,	mental	health	care	ser-
vice seems to offer the most adequate treatment 
for them.
Here it is worth to present the results of 
a study evaluating medical care and treatment 
in	the	newly	established	Medically	Unexplained	
Symptoms	Clinic	(MUS	Clinic)	in	London	[22].	
The	authors	emphasize	the	fact	that	the	vast	
majority of patients admitted to the diagnos-
tics suffered primarily from previously unde-
tected	mental	health	disorders.	Most	often	pa-
tients were diagnosed with depression and anx-
iety disorders, which implies two further issues. 
One	of	them	is	the	need	to	improve	the	efficien-
cy of recognition of these disorders at primary 
and secondary health care [23]. The second issue 
is related to diagnostic difficulties with clinical 
manifestations of depression and anxiety disor-
ders, which could be restricted to somatic symp-
toms [24, 25].
Guidelines and treatment pathways
British guidelines for dealing with chest pain 
of 2010 [26] does not recommend further pro-
ceedings based on the assumption that the mere 
recognition of the absence of organic heart dis-
ease will improve the patient’s condition [27]. 
The	current	German	guidelines	regarding	the	
psychosocial	factors	in	cardiology	(2013)	include	
the area of psychosocial functioning as an im-
portant etiologic factor in the development and 
prognosis	of	coronary	artery	disease	(recom-
mendations	I	A).	Loneliness,	lack	of	social	sup-
port, death of a partner, similarly to depression, 
depressed mood, anxiety, hostility, or PTSD, are 
an independent etiological factors of coronary 
heart disease development. They have a nega-
tive impact on both the prognosis and the pres-
ence of complications during treatment [28]. 
These guidelines recommend to diagnose and 
treat psychiatric disorders as a part of the pre-
vention	of	coronary	heart	disease	(I	B).	Numer-
ous reports support the aforementioned recom-
mendations.	Ashley	M.	Harris	et	al.	observed	
that comorbidity of mental disorders in patients 
without diagnosed organic disease who report 
somatic symptoms is more than four times high-
er than in patients with organic diagnoses, and 
reaches	60%	[29].	In	another	study,	psychiatric	
diagnosis	was	present	in	75%	of	patients	report-
ing somatic symptoms with no evidence of or-
ganic disease. Panic disorder was diagnosed in 
a	half	of	the	studied	patients	(47.1%),	and	de-
pression	in	21.4%	of	patients.	Generalized	anx-
iety disorder and obsessive-compulsive disor-
ders	were	diagnosed	in	5.7%	of	patients,	and	
less	than	3%	of	patients	were	diagnosed	with	
somatoform disorders. The most common com-
plaint	in	patients	with	generalized	anxiety	dis-
order and panic disorders was the conviction of 
heart disease [30].
Moreover,	anxiety	disorders,	depression,	de-
pressed mood or loneliness separately, are an 
important	risk	factors	for	cardiovascular	diseas-
es. Due to the frequent comorbidity of mental 
illness with cardiovascular diseases and worse 
prognosis for this coincidence, it is important to 
extract mentally disturbed person from the pop-
ulation of people suffering from cardiovascular 
diseases.	In	accordance	with	current	knowledge,	
the assessment of mental functions is an impor-
tant element in the diagnostic and therapeutic 
process in patients with cardiac symptoms, ir-
respective of diagnosis of organic heart disease.
Another study suggests that understanding 
the essence of reported complaints provides re-
lief for patients and it may be an intervention 
with positive therapeutic outcomes [27]. Unfor-
tunately, as reported in studies, psychosomat-
ic disorders are diagnosed too rarely in prima-
ry care [31]. This situation has many causes [32], 
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among other things, it is doctor’s fear of over-
looking	“serious	illness”	[7]	and	the	lack	of	clear	
diagnostic	pathways.	In	ICD-10	and	DSM-IV	so-
matization	disorder	is	diagnosed	after	the	exclu-
sion of organic cause, which often is very diffi-
cult.	The	reports	also	highlight	the	lack	of	EBM	
(Evidence-based	medicine)	based	guidelines	
for the management of patients reporting med-
ical condition without organic explanation [33]. 
In	2012,	in	Germany,	for	the	first	time,	an	inter-
disciplinary team of specialists in medicine and 
psychosocial sciences, together with a represent-
ative of patients led to the drafting of guidelines 
for	dealing	with	somatoform	disorders.	Innova-
tions	in	this	edition	of	the	Guidelines	include	i.a.	
emphasis to features of the doctor-patient rela-
tionship important in the treatment of somato-
form	disorders,	taking	into	account	also	iatro-
genic areas [34].
Transient myocardial ischemia and stress-induced 
cardiomyopathy as psychosomatic syndromes
	In	2012,	carbon	dioxide	challenge	test	imitat-
ing	panic	attack	triggering	myocardial	ischemia	
was described. The experiment was conduct-
ed in a man with a long history of occurrence 
of	panic	attacks	in	the	course	of	agoraphobia.	
The study is important due to the fact that the 
impact	of	a	panic	attack	on	disturbances	of	my-
ocardial perfusion in patients without structur-
al heart disease has been experimentally demon-
strated for the first time. During the study, the 
patient reported mild chest pain, palpitations 
and	dizziness.	There	has	been	an	increase	in	
blood	pressure	to	190/100	mmHg	and	increased	
heart	rate,	oxygen	saturation	remained	at	98%.	
No	ischemic	changes	were	observed	in	ECG,	
whereas single-photon emission tomography 
image demonstrated reversible myocardial is-
chemia	[35].	Currently	it	is	known	that	different	
mechanisms are responsible for triggering pain 
in	the	chest	during	a	panic	attack	[36].	The	one	
most often mentioned is hyperventilation which 
causes	respiratory	alkalosis.	It	is	related	to	cal-
cium influx into the cells, which induces spasm 
of coronary arteries resulting in myocardial is-
chemia	[37].	In	the	described	case,	despite	over-
activity of the adrenergic system recorded dur-
ing the test, the patient denied the occurrence 
of	a	panic	attack.	The	explanation	may	be	found	
in a study by Bernard D. Beitman et al., where 
it	has	been	noted	that	up	to	32-41%	of	patients	
with anginal pain without coronary artery dis-
ease do not feel fear when experiencing a pan-
ic	attack	[38].
Takotsubo	cardiomyopathy	–	in	other	words	
stress-induced	cardiomyopathy	(Transient	left	
ventricular apical ballooning syndrome – TL-
VABS)	has	the	similarly	transient	nature	of	is-
chemia.	It	is	manifested	by	pain	in	the	chest,	
shortness of breath, hypotension and changes in 
ECG	as	in	a	myocardial	infarction.	The	diagno-
sis is based on 1) the presence of transient dys-
kinesia	of	left	ventricular	apex	and	the	centre	of	
the ventricle, comprising an area of vascularisa-
tion	of	more	than	one	coronary	artery;	2)	the	lack	
of	significant	coronary	artery	disease	and	lack	
of angiographic characteristics of plaque rup-
ture;	3)	new	changes	in	ECG;	and	4)	the	exclu-
sion of the presence of a pheochromocytoma or 
myocarditis. The described cardiomyopathy is 
associated with a good prognosis and with full 
recovery	in	up	to	4	weeks.	Mortality	varies	be-
tween	0%	and	8%	[39].	It	is	estimated	to	occur	in	
0.02%	of	the	population	of	the	United	States,	of	
which	89%	are	women,	especially	in	postmen-
opausal	period	[40].	It	is	often	comorbid	with	
cerebrovascular diseases and psychiatric disor-
ders, including anxiety disorders, mood disor-
ders, as well as with liver failure, sepsis and can-
cer [41-42]. The exact mechanism of symptoms 
is	still	unknown.	It	is	believed	that	the	symp-
toms of cardiomyopathy are the result of severe 
stress, which occurs due to the release of cat-
echolamines. The excess of catecholamines af-
fects the modification of beta2-adrenergic recep-
tors, leads to vasoconstriction, accumulation of 
toxic	metabolites,	and	consequently	blocks	the	
contractility of certain areas of the heart mus-
cle. This thesis is confirmed by reports on occur-
rence of cardiomyopathy, similar to that in Ta-
kotsubo	cardiomyopathy,	in	patients	with	a	di-
agnosis	of	pheochromocytoma.	In	this	case,	re-
moval of the catecholamine-producing tumor 
results in left ventricular failure remission [43]. 
Some authors also believe that the described car-
diomyopathy has a protective function, which 
allows a patient to survive a stressful situation 
without permanent damage to the myocardi-
um [44]. The researchers suggest that the same 
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protective function is performed by dissociative 
amnesia	for	the	psyche.	In	people	who	have	ex-
perienced dissociative amnesia after traumatic 
events, the prevalence of posttraumatic stress 
disorder	(PTSD)	is	lower	[45]	[46,	47].	In	2014,	
Amir Toussi et al. reported, for the first time, 
a	case	of	a	woman	in	whom	Takotsubo	cardio-
myopathy was accompanied by the occurrence 
of dissociative amnesia in reaction to her sister’s 
death [48]. The researchers suggest that dysreg-
ulation of glutamate levels in the blood and in-
creased levels of catecholamines might be the 
mechanism responsible for the occurrence of dis-
sociation in the course of transition cardiomy-
opathy	[47,	49,	50].	Knowledge	on	the	issue	of	
these interdependencies is still incomplete and 
requires further studies.
Psychocardiology and the comorbidity
Bearing in mind the strong interdependen-
cies between heart diseases and mental health, 
a new field of science – psychocardiology – has 
been created. Psychocardiology combines medi-
cal	thinking	and	psychology.	It	is	impossible	not	
to mention that Poland is one of the first coun-
tries	which	recognized	the	role	of	psychologi-
cal problems in patients with cardiovascular dis-
eases.	In	1961	prof.	Zdzislaw	Askanas	opened	
psychological	laboratory	at	the	Institute	of	Car-
diology,	Medical	University	of	Warsaw,	one	of	
the	first	of	its	kind	in	Europe	[51].	The	benefi-
cial effects of cooperation of cardiologists and 
psychologists has been confirmed by the results 
of meta-analysis of 43 studies on psychological 
interventions in patients suffering from cardio-
vascular disorders. During the two year observa-
tion of patients with heart disease who simulta-
neously participated in psychological interven-
tions, it has been shown that the mortality rate 
in	this	group	decreased	by	27%	compared	with	
patients who were monitored only by an intern-
ist.	Moreover,	in	the	long	perspective	frequency	
of	disease	reoccurrence	was	lower	by	43%.	Re-
searchers explain the relationship between car-
diology and psychology by common pathophys-
iologic	and	behavioral	mechanisms.	On	the	one	
hand psychologic factors may activate some neg-
ative pathophysiologic metabolic pathways, on 
the other, negative psychosocial conditions may 
promote unhealthy behavior [52].
The current review of studies [53] on the con-
tribution of depression in the global prevalence 
of	coronary	artery	disease	(CAD)	suggests	that	
the	risk	of	its	development	is	increased	in	peo-
ple	with	depression	by	56%,	and	that	depression	
is	responsible	for	2.95%	of	DALYs	(Disability-ad-
justed life year – years of life lost due to prema-
ture death or bodily injury resulting from trau-
ma or disease) associated with CAD. Bacon et 
al.	(2014)	showed	that	patients	diagnosed	with	
an	anxiety	disorder	are	four	times	more	likely	to	
develop hypertension during one year of obser-
vation. Contradictory information has been ob-
tained in the study on the relationship between 
depression	and	hypertension.	In	the	meta-anal-
ysis of prospective studies, results suggest that 
depression increases the incidence of hyperten-
sion	by	42%	[54].	On	the	other	hand,	the	larg-
est prospective study on this issue, including 
36,000	people,	that	is	about	50%	more	than	the	
entire meta-analysis, does not confirm these re-
sults.	In	follow-up	examinations	after	11	and	22	
years, the obtained results showed a combina-
tion of intensification of depressive symptoms 
with lower blood pressure [55, 56]. The expla-
nation for these discrepancies could be other re-
ports suggesting that only affective symptoms of 
depression impact the sympathetic nervous sys-
tem dysfunction. Somatic component and the to-
tal score on a scale of depression have no signif-
icant influence [57].
Mechanisms of symptoms
Regulation of emotions
Trying to understand how psychology af-
fects somatics, it is impossible not to mention 
the concepts of diseases stemming from psy-
choanalytic	 thinking.	Some	theorists	believe	
that it is useless to distinguish psychosomatic 
illnesses from other diseases, as most somatic 
disorders have mental aspect, as well as men-
tal illnesses have somatic aspect. They empha-
size	the	fact	of	non-existence	of	simple	cause	
and	effect	relation	between	the	“‘psyche”	and	
“soma”	[58].	Aleksandrowicz	also	says	that	neu-
rosis and their psychotherapy are an integral 
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part	of	medicine	and	medical	tasks	and	signif-
icantly exceed outside the scope of psychiatry 
[59].	Such	thinking	is	supported	by	the	theory	
of	emotional	regulation	developed	by	Graeme	
J.Taylor	[60],	which	does	not	distinguish	organ-
ic and functional, physical or mental diseases, 
treating them as impaired regulation of various 
sub-systems	of	the	body.	In	this	approach,	each	
illness is psychosomatic, as they can be accom-
panied by both physiological and mental chang-
es. Sigmund Freud presented a similar way of 
thinking	over	120	years	ago.	In	addition	to	the	
symptoms of conversion neurosis, of symbol-
ic significance, he mentioned actual neurosis 
whose bodily symptoms were the result of lim-
ited capacity to cope with tension [61]. This the-
ory	seems	to	be	confirmed	by	Kyung	Bong	Koh.	
In	his	study,	based	on	47	patients,	he	showed	
that suppression of anger was a predictor of so-
matic symptoms [62]. Similarly, in patients after 
myocardial infarction, the intensification of so-
matization	was	associated	with	blocking	the	ex-
pression of unpleasant emotions [63]. Liang Liu 
et al. showed that, the tendency to react with 
anger, on the one hand, and excessive suppres-
sion, on the other, play an important role in the 
emergence of somatic symptoms in people with 
anxious-ambivalent	attachment	style.	In	this	ap-
proach, the intervention directed to the ability 
to express and cope with feelings, could reduce, 
in some people, a tendency to present medical-
ly unexplained symptoms [13].
Alexithymia
The term alexithymia is defined as difficulty 
in identifying and expressing emotions, pover-
ty of imagination and externally-oriented way of 
thinking	[64].	Its	relations	with	both	mental	ill-
nesses and somatic diseases [65] including de-
pression [66], anxiety disorders [67], eating dis-
orders [68], hypertension [69], diabetes [70] and 
psoriasis [71] have been reported. Alexithymic 
features are relatively common in the general 
population,	occurring	in	10%	of	adults,	slight-
ly more frequently in men [72]. There are many 
concepts	of	its	development.	Genetic,	neurobio-
logical and environmental factors are considered 
to	be	essential.	Referring	to	the	etiology,	Hell-
muth Freiberger [73] introduced a distinction be-
tween primary alexithymia – a genetically deter-
mined personality traits and secondary alexithy-
mia – which is a defense mechanism for experi-
enced trauma [74, 75].
A study comparing the features of alexithymia 
in patients suffering from cardiovascular disor-
ders and mood disorders showed an increased 
overall level of alexithymia in both groups. 
Higher score in terms of poverty of imagina-
tion and a lower emotional excitability have 
been observed among patients with cardiovas-
cular	diseases.	In	contrast,	more	intense	charac-
teristics	–	the	difficulty	in	verbalizing	emotional	
experience and poor insight into own emotion-
al experience – have been observed in patients 
with mood disorders. Dysregulation of auto-
nomic nervous system is considered to be the 
pathomechanism responsible for comorbidity 
of alexithymia and cardiovascular diseases [76]. 
The gap between the intensity of the emotional 
response and recorded reaction of the autonom-
ic nervous system, described in other publica-
tions [77], has been also observed in the study 
[78].	According	to	Henry	Krystal,	lack	of	access	
to conscious experiencing the affective content 
in alexithymic patients leads to its disclosure in 
the	body,	i.e.	somatization	[2].
Theory of the desomatization – resomatization
The occurrence of somatic symptoms without 
organic cause related to illness is also explained 
by the psychoanalytic concept of early trauma. 
Krystal,	explaining	the	genesis	of	psychosomat-
ic disorders, drew attention to the difficulties in 
diagnosis	of	emotional	states	arising	from	block-
ing	the	processes	of	differentiation,	verbalization	
and	desomatization	of	child’s	affect	on	the	ba-
sis of deprivation of the child’s needs at an ear-
ly stage of development. He believed that alex-
ithymic people are the people who experienced 
trauma in early childhood. Consequently, in the 
face of overwhelming fear, it leads to the phe-
nomenon of regression, resulting in secondary 
somatization	(resomatization) of mental process-
es. People who have experienced long-term trau-
ma	in	childhood,	could	fail	in	desomatization.	
As a result, the presentation of mental states is 
not transferred from the body into the realm of 
mind	[2].	Currently,	it	seems	reasonable	to	ask	
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about the diagnosis and treatment of difficulties 
associated	with	recognizing	one’s	own	emotion-
al states in terms of prevention or potentiation of 
treatment of somatic diseases.
Functional imaging
The literature extensively describes changes 
in the nervous system of patients with mental 
disorders, including psychosomatic symptoms. 
The observation of these changes is possible by 
functional imaging techniques, such as func-
tional	nuclear	magnetic	resonance	(fMRI),	sin-
gle	photon	emission	tomography	(SPECT),	mag-
netoencephalography	(MEG)	and	positron	emis-
sion	tomography	(PET).	As	an	example,	there	is	
a study in which the neurophysiological basis of 
alexithymia, indicating a malfunction of anterior 
cingulate gyrus has been evaluated [79-81]. Has-
se	Karlsson	et	al.,	have	found	that	the	reduced	
activation of the anterior cingulate gyrus is also 
correlated with the increase in the activation 
of the motor and somatosensory cortex, which 
could explain the mechanism of occurrence of 
somatic	symptoms	with	the	lack	of	recognition	
of	experienced	emotions.	Julian	F.	Thayer	et	al.	
created a neurophysiological model of emotion 
regulation on the basis of functional examination 
[82]. According to him, during emotional stress 
increases the activity of the limbic system and 
certain prefrontal areas and there is a general de-
crease in activity of the prefrontal cortex, which 
triggers the automatic system of behavior con-
trol [83]. This concept corresponds with mod-
el of cognitive-emotional impulse control pro-
posed	by	Sylvie	J	M	van der Kruijs [84]. Explain-
ing the phenomenon of dissociation, the model 
assumes that in the optimal emotional state the 
motor areas of the brain to a small extent are af-
fected by emotions. However, in case of inten-
sive emotional arousal, the centre responsible for 
the cognitive processing of excitation is omitted. 
In	the	imaging	examination,	the	described	mod-
el appears to be an increase in functional con-
nection of the motor cortex with the limbic sys-
tem with reduced prefrontal cortex impulsation. 
In	another	report,	the	researchers	suggest	that	
the	phenomenon	of	somatization	measured	us-
ing	a	self-assessment	questionnaire	(SOMS-2)	is	
associated with increased activity in the anteri-
or ventral precuneus, posterior cingulate gyrus 
and anterior medial thalamus, and that the auto-
nomic nervous system affects the occurrence and 
severity of symptom in the body. At the same 
time the researchers pay attention to the fact that 
their findings are consistent with the theory, ac-
cording	to	which	somatization	is	associated	with	
cognitive	style	characterized	by	affective	content	
rumination [85].
Diagnostics and treatment
In	addition	to	the	broad	diagnostic	capabili-
ties, functional examination enables an assess-
ment of the impact of pharmacological and psy-
chotherapeutic treatment on nervous system me-
tabolism modification, which in recent years has 
been	repeatedly	demonstrated	[86].	It	must	be	
remembered that modern methods of brain im-
aging, although they are a milestone for the de-
velopment	of	medical	knowledge	and	make	it	
possible to objectify the diagnosis and assess-
ment of treatment effects, are burdened with the 
necessity of scientific reductionism in describing 
mental processes [87].
The	 clinical	management	 still	 lacks	 clear	
guidelines for psychological and psychiatric di-
agnosis in patients with symptoms which sug-
gest	somatization.	Due	to	the	high	comorbidity	
of somatic diseases with mental disorders, the 
implementation of diagnostic screening for men-
tal health disorders, appears to be indispensa-
ble	at	some	stage.	Moreover,	the	conclusions	of	
a meta-analysis of several studies clearly confirm 
that, in the treatment of somatoform disorders, 
psychotherapy is more effective than standard 
method	(d=0.80	vs.	d=0.31,	p	<0.05)	[87].	Control	
studies show that the positive effect of the treat-
ment occurs in case of psychotherapy and physi-
cal exercises, but it has not been observed for the 
administration of medicines [88-91]. Changes in 
DSM-5	come	in	the	aid	of	diagnosticians,	free-
ing them from the necessity to exclude organic 
cause in the case of unexplained somatic symp-
toms. Such an approach is also close to the psy-
choanalytic	perspective.	In	psychotherapy,	pa-
tients with somatic symptoms of mental disor-
ders, the prospect of an organic explanation of 
complaints by the appropriate expert inhibits the 
progress of therapy.
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The	treatment	of	these	diseases	emphasizes	
the importance of awareness, disclosure and ex-
periencing emotions, which is the core of psy-
chodynamic	psychotherapy	[92].	In	studies	in	
the general population it has been shown that 
training in naming emotions and reading liter-
ary fiction [93] is beneficial for identifying one’s 
own emotional states and affective regulation 
[94]. Psychotherapy also reduces the symptoms 
of alexithymia, although there is still a need to 
develop	an	individualized	procedure	in	this	re-
spect	[95].	In	examining	the	impact	of	pharma-
cology,	Anthony	Lane	et	al.	(2013)	showed	that	
oxytocin administered intranasally increase peo-
ple’s will to share their painful emotions [96]. 
Another therapeutic option is transcranial mag-
netic stimulation of the brain areas responsible 
for experiencing emotions and linguistic prop-
erties [97, 98]. Further studies in this regard, as-
sessing various therapeutic interventions in ran-
domized	trials	are	needed.
Recapitulation
In	medical	practice	we	often	meet	patients	
with somatic symptoms without organic cause. 
In	this	case,	usually	reported	symptoms	are	ac-
companied by undiagnosed mental health prob-
lems, which are often a significant factor in the 
risk	of	serious	somatic	illness.	Despite	the	lack	of	
a diagnosed organic cause, these symptoms are 
a cause of disability and withdrawal from nor-
mal	social	life.	In	addition,	deepening	and	re-
peating diagnostic test for unexplained somat-
ic symptoms increases patient’s anxiety, which 
exacerbate symptoms, and generates considera-
ble cost to the health care system. Unfortunate-
ly,	there	is	still	a	lack	of	clear	guidelines	for	di-
agnosis and treatment of psychosomatic disor-
ders in primary care, and in many departments 
involved in the treatment of somatic illnesses.
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